243 related articles for article (PubMed ID: 38255798)
1. A Systematic Review of the Metabolism of High-Grade Gliomas: Current Targeted Therapies and Future Perspectives.
De Maria L; Panciani PP; Zeppieri M; Ius T; Serioli S; Piazza A; Di Giovanni E; Fontanella MM; Agosti E
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255798
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Biopsy versus resection for the management of low-grade gliomas.
Jiang B; Chaichana K; Veeravagu A; Chang SD; Black KL; Patil CG
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009319. PubMed ID: 28447767
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapies for high-grade glioma.
Norden AD; Drappatz J; Wen PY
Nat Rev Neurol; 2009 Nov; 5(11):610-20. PubMed ID: 19826401
[TBL] [Abstract][Full Text] [Related]
8. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted therapies for recurrent glioblastoma: current and future targets.
Lau D; Magill ST; Aghi MK
Neurosurg Focus; 2014 Dec; 37(6):E15. PubMed ID: 25434384
[TBL] [Abstract][Full Text] [Related]
10. Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies.
Agosti E; Zeppieri M; Antonietti S; Ius T; Fontanella MM; Panciani PP
J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38541003
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas.
Mudassar F; Shen H; O'Neill G; Hau E
J Exp Clin Cancer Res; 2020 Oct; 39(1):208. PubMed ID: 33028364
[TBL] [Abstract][Full Text] [Related]
12. Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II).
Giotta Lucifero A; Luzzi S
Brain Sci; 2021 Jul; 11(8):. PubMed ID: 34439595
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
14. Chordoma Genetic Aberrations and Targeted Therapies Panorama: A Systematic Literature Review.
Agosti E; Antonietti S; Zeppieri M; Ius T; Fiorindi A; Tel A; Robiony M; Panciani PP; Fontanella MM
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731241
[No Abstract] [Full Text] [Related]
15. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
17. Overview on current treatment standards in high-grade gliomas.
Pellerino A; Franchino F; Soffietti R; Rudà R
Q J Nucl Med Mol Imaging; 2018 Sep; 62(3):225-238. PubMed ID: 29696949
[TBL] [Abstract][Full Text] [Related]
18. Identification of the immune gene expression signature associated with recurrence of high-grade gliomas.
Roura AJ; Gielniewski B; Pilanc P; Szadkowska P; Maleszewska M; Krol SK; Czepko R; Kaspera W; Wojtas B; Kaminska B
J Mol Med (Berl); 2021 Feb; 99(2):241-255. PubMed ID: 33215304
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
20. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
